Under an agreement with the federal government, Merck & Co. Inc. will receive up to roughly $356 million to manufacture and develop its MK-7110 treatment for Covid-19. "Merck to Supply U.S. With Covid-19 Therapeutic," published at 6:56 a.m. ET, incorrectly said Merck would receive up to roughly $256 million in the deal.

(END) Dow Jones Newswires

December 23, 2020 07:18 ET (12:18 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Merck Charts.